When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Rivaroxaban - Wikipedia

   en.wikipedia.org/wiki/Rivaroxaban

   Rivaroxaban, sold under the brand name Xarelto among others, is an anticoagulant medication (blood thinner) used to treat and prevent blood clots. [8] Specifically it is used to treat deep vein thrombosis and pulmonary emboli and prevent blood clots in atrial fibrillation and following hip or knee surgery. [ 8 ]

3. Valpak - Wikipedia

   en.wikipedia.org/wiki/Valpak

   Valpak prints, packages and ships coupon envelopes from the Valpak Manufacturing Center, a $200-million, 500,000-square-foot print production facility in St. Petersburg. [6] Print inserts in the envelope advertise local businesses and national brands with coupons for dining, health and beauty, entertainment, automotive, home services and more.

4. Direct factor Xa inhibitors - Wikipedia

   en.wikipedia.org/wiki/Direct_factor_Xa_inhibitors

   Side effects may include bleeding, most commonly from the nose, gastrointestinal tract (GI) or genitourinary system. [2] Compared to the risk of bleeding with warfarin use, direct factor Xa inhibitors have a higher risk of GI bleeding, but lower risk of bleeding in the brain. [2]

5. 4 strategies for getting manufacturer coupons - AOL

   www.aol.com/news/2010-03-11-4-strategies-for...

   For premium support please call: 800-290-4726 more ways to reach us

6. Xarelto to Become First Prescription Drug With TV Ads That ...

   www.aol.com/news/xarelto-become-first...

   For premium support please call: 800-290-4726 more ways to reach us

7. Rebate (marketing) - Wikipedia

   en.wikipedia.org/wiki/Rebate_(marketing)

   An MIR entitles the buyer to mail in a coupon, receipt, and barcode in order to receive a check for a particular amount, depending on the particular product, time, and often place of purchase. Rebates are offered by either the retailer or the product manufacturer.

8. Quotient Technology - Wikipedia

   en.wikipedia.org/wiki/Quotient_Technology

   Quotient Technology, formerly Coupons.com, Inc., was founded in 1998 by Steven Boal, former CEO. Coupons.com originally was a website for finding and printing coupons. The website eventually expanded to the Coupons.com app, which enabled consumers to redeem cashback offers and load offers to loyalty cards, as well as find printable coupons.

9. Discovery and development of direct Xa inhibitors - Wikipedia

   en.wikipedia.org/wiki/Discovery_and_development...

   Rivaroxaban (Xarelto) was the first approved FXa inhibitor to become commercially available in Europe and Canada in 2008. [1] The second one was apixaban (Eliquis), approved in Europe in 2011 [2] and in the United States in 2012. [3] The third one edoxaban (Lixiana, Savaysa) was approved in Japan in 2011 and in Europe and the US in 2015. [4]